Cargando…
Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals
Chronic hepatitis C virus (HCV) infection is a serious public health problem worldwide. China, as the country with the largest number of HCV infections in the world, plays a significant role in eliminating hepatitis C. Due to different financial situations and education background, hepatitis C patie...
Autores principales: | Bian, Dan-Dan, Zhou, Hai-Yang, Liu, Shuang, Liu, Mei, Duan, Carol, Zhang, Jin-Yan, Jiang, Ying-Ying, Wang, Ting, Chen, Yu, Wang, Zhao, Zheng, Su-Jun, Duan, Zhong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572026/ https://www.ncbi.nlm.nih.gov/pubmed/28834904 http://dx.doi.org/10.1097/MD.0000000000007885 |
Ejemplares similares
-
Up-regulation of Plasma Hexosylceramide (d18:1/18:1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort Study
por: Zhang, Jin-Yan, et al.
Publicado: (2016) -
The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial
por: Cao, Yaping, et al.
Publicado: (2021) -
Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report
por: Zhao, Dan-Tong, et al.
Publicado: (2020) -
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
por: Ma, Hong, et al.
Publicado: (2016) -
Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China
por: Li, Xu, et al.
Publicado: (2016)